The inflammatory response in mild and in severe psoriasis.
about
Promising new treatments for psoriasisPlasma total antioxidant capacity and peroxidation biomarkers in psoriasisBiomarkers of An Autoimmune Skin Disease--PsoriasisCo-morbidity in psoriasis: mechanisms and implications for treatment.Abnormal isoaspartyl residues in erythrocyte membranes from psoriatic patients.Psoriasis and comorbidities: links and risks.Calcitriol inhibits keratinocyte proliferation by upregulating leukocyte elastase inhibitor (serpin B1).Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literatureMean platelet volume is elevated in patients with psoriasis vulgaris.Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin.Enhanced ferritin/iron ratio in psoriasis.Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis.The evolution of the psoriatic lesion.Psoriasis comorbidities.Lactoferrin in Gingival Crevicular Fluid and Peripheral Blood during Experimental Gingivitis.Cardiometabolic risk in psoriasis: differential effects of biologic agents.Psoriasis comorbidities.Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.The roles of cells and cytokines in the pathogenesis of psoriasis.Selenium and psoriasis.Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis.C-reactive protein in psoriasis: a review of the literature.C-reactive protein and uric Acid levels in patients with psoriasisLessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA.Red blood cell distribution width is increased in patients with psoriasis vulgaris: A retrospective study on 261 patients.Comparative Analysis of Serum Copper, Iron, Ceruloplasmin, and Transferrin Levels in Mild and Severe Psoriasis Vulgaris in Iranian Patients.Olfactory functions in patients with psoriasis vulgaris: correlations with the severity of the disease.Frequency and characteristics of circulating CD4(+) CD28(null) T cells in patients with psoriasis.Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis.Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity.The serum levels of malondialdehyde, vitamin e and erythrocyte catalase activity in psoriasis patients.The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.Studies on serum 8-hydroxy guanosine (8-OHdG) as reliable biomarker for psoriasis.Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study.Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.Associated comorbidities in psoriasis and inflammatory bowel disease.A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress.Effects of elastase and cathepsin G on the levels of membrane and soluble TNFalpha.Stem bark and flower extracts of Vismia cauliflora are highly effective antioxidants to human blood cells by preventing oxidative burst in neutrophils and oxidative damage in erythrocytes.
P2860
Q24598008-1860F1F0-8D9E-49D2-8E8A-1B46325F0B39Q26744708-2C84AE49-C2A7-4BE0-BF03-A4882EC1E25CQ26781378-C352E8DE-2763-466D-BAE9-C06FF590BBD1Q30248952-4BC8BED7-02A7-49AC-BE23-11103D489C39Q30417395-B98076AC-8763-48C3-A419-078F07A9D3EAQ34418506-8457AEB7-2913-44FB-9C95-66F1AEF87332Q35153480-C2499D1B-F0EB-454C-8664-204CE8B78698Q35168945-59465890-87B3-4579-B2DE-26480A7A9A05Q35421660-FB4E6925-956B-467B-B40F-5ADBD5047397Q36094366-46F9DBC5-4843-4125-9EE4-808CADA01BEBQ36107635-FBA97265-E5DA-4840-8178-4BD1E41492ADQ36124545-D337C859-7672-40FC-A9AB-F2C227496703Q36853157-B26909BA-9C31-4F8D-AD77-005DBE8CBB4CQ37084274-8B6C1EC8-1244-44A9-9146-4D6500DCB315Q37110070-F0373DB3-550B-44C5-BA26-78E2F17A2B96Q37145684-336BD83D-BAFE-486F-A9A9-EFD185145D5FQ37607422-DBC38EE9-D079-4356-A698-8EFAA3544B0BQ37673703-A72C248C-2444-4B14-8B9F-5192775A4B63Q37995658-99723418-EBD6-4350-ABDA-8B9299854825Q38028409-4CC0EAAC-65E2-4FC4-9066-BFF4DBE0C162Q38095512-AF1A31BC-A634-49AA-B63D-2E78CD2FB741Q38133614-04DFA19E-A3EA-4572-B914-7355A31A7228Q38266480-C2CC451D-487A-455D-A54A-7E02E37AD0EAQ38972679-BC045FCE-A3EE-45B7-8F02-9FD7D136B9EAQ39136407-4D36C5F5-2D4F-49F6-A22B-72C48F168588Q40100186-67D5C934-96A9-45FF-9B50-2BA8000A78C5Q40702053-2AD461C1-805A-4440-A28C-D06392C2ECD9Q40778252-E5D5FA83-5454-466B-A480-94916AB895ACQ41693144-18FF9A68-AD91-4365-99EE-56E9BF7FB3E6Q42756886-BC88CD73-CF32-439C-8573-48E8176979B9Q42860247-0E15236F-D5EA-46E1-8A64-803A200E5E63Q43100840-E3D81831-22C5-48C9-A69B-FBFD931AD01CQ43760972-CABBE9B6-69B9-46F3-AF48-EC7CB794EC32Q44799660-8044E73E-57FD-499D-AAEB-EA77C1DA0EF9Q44942262-88165602-5127-44B6-8CED-439D02449D73Q45891109-2A2795A9-9AB4-4663-8E5E-C37C0CA9721FQ45907246-F4E2DB5E-BC01-4568-874B-DABB184838AFQ46600938-263FA836-2359-4BCA-8727-D0F3F1FCEEA6Q46733359-2BB21E56-BA60-4B35-BE14-8F55FC66D4A9Q46744385-77349500-19E0-4374-9937-4295F4AA01A2
P2860
The inflammatory response in mild and in severe psoriasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The inflammatory response in mild and in severe psoriasis.
@en
The inflammatory response in mild and in severe psoriasis.
@nl
type
label
The inflammatory response in mild and in severe psoriasis.
@en
The inflammatory response in mild and in severe psoriasis.
@nl
prefLabel
The inflammatory response in mild and in severe psoriasis.
@en
The inflammatory response in mild and in severe psoriasis.
@nl
P2860
P50
P1476
The inflammatory response in mild and in severe psoriasis.
@en
P2860
P304
P356
10.1111/J.1365-2133.2004.05984.X
P407
P50
P577
2004-05-01T00:00:00Z